XML 27 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net loss $ (68,495) $ (59,351) $ (58,763)
Depreciation, amortization, and abandonment costs 2,707 2,412 7,677
Stock-based compensation expenses 23,645 17,065 5,114
Amortization of deferred contract acquisition and fulfillment costs 10,865 8,075 4,231
Change in valuation of warrants to purchase preferred and common stock 0 15,046 41,505
Non-cash interest expense (income), net (146) 331 263
Non-cash expenses with respect to stockholders’ loans 0 882 0
Loss (gain) on sale of property and equipment 185 (757) 0
Loss on foreign exchange 1,424 0 0
Increase in trade receivables (11,277) (1,057) (6,274)
Decrease (increase) in prepaid expenses and other current assets and other assets, noncurrent 429 (2,299) (864)
Increase in deferred contract acquisition and fulfillment costs (11,558) (18,051) (12,947)
Increase in trade payables 3,132 3,886 2,064
Increase (decrease) in accrued expenses and other current liabilities (1,937) 3,756 4,964
Increase (decrease) in employees and payroll accruals (3,743) 2,352 5,886
Increase (decrease) in other liabilities, noncurrent (51) (675) 635
Increase in deferred revenue 7,465 6,275 12,313
Operating lease right-of-use assets and lease liabilities, net 527 0 0
Net cash provided by (used in) operating activities (46,828) (22,110) 5,804
Cash flows from investing activities:      
Investment in available-for-sale marketable securities (60,165) 0 0
Proceeds from maturities of available-for-sale marketable securities 18,985 0 0
Net cash acquired in business combination 0 0 383
Purchases of property and equipment (1,218) (1,876) (1,118)
Proceeds from sale of property and equipment 0 757 0
Capitalized internal-use software development costs (4,759) (3,978) (1,849)
Investment in restricted bank deposit (2,600) 0 0
Purchase of intangible assets 0 (145) (162)
Net cash used in investing activities (49,757) (5,242) (2,746)
Cash flows from financing activities:      
Proceeds from initial public offering, net of underwriting discounts and commissions 0 160,425 0
Payment related to the conversion of Series F redeemable convertible preferred stock upon initial public offering 0 (1,569) 0
Proceeds from long-term loans, net of debt issuance cost 0 41,915 2,000
Repayment of long-term loans (3,000) (51,833) (1,667)
Principal payments on finance leases (136) (1,717) (2,354)
Proceeds from exercise of stock options 2,732 1,335 280
Payment of debt issuance costs (125) 0 0
Payment of deferred offering costs 0 (5,188) (106)
Net Cash Provided by (Used in) Financing Activities (529) 143,368 (1,847)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations (1,424) 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash (98,538) 116,016 1,211
Cash, cash equivalents and restricted cash at the beginning of the year 144,371 28,355 27,144
Cash, cash equivalents and restricted cash at the end of the year 45,833 144,371 28,355
Supplemental disclosure of non-cash activity:      
Purchase of property, equipment, internal-use software, and intangible asset in credit 355 1,106 155
Lease liabilities arising from right-of-use assets 23,712 0 0
Capitalized stock-based compensation cost 296 0 0
Pending proceeds from option exercises 227 0 0
Lease incentive recognized as leasehold improvements 1,711 0 0
Conversion of warrants to common stock upon initial public offering 0 70,677 0
Conversion of convertible and redeemable convertible preferred stock to common stock upon initial public offering 0 161,261 0
Issuance of ordinary shares and warrant with respect to business combination 0 0 3,799
Unpaid deferred offering costs 0 0 976
Supplemental disclosure of cash flow information      
Cash paid for income taxes, net 8,873 2,636 1,210
Cash paid for interest 2,301 1,944 3,947
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheet      
Cash and cash equivalents 44,625 143,949 27,711
Restricted cash included in other assets, noncurrent 1,208 422 644
Total cash, cash equivalents, and restricted cash $ 45,833 $ 144,371 $ 28,355